These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 26237629

  • 1. Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.
    Tremoulet AH, Dutkowski J, Sato Y, Kanegaye JT, Ling XB, Burns JC.
    Pediatr Res; 2015 Nov; 78(5):547-53. PubMed ID: 26237629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.
    Ko TM, Kuo HC, Chang JS, Chen SP, Liu YM, Chen HW, Tsai FJ, Lee YC, Chen CH, Wu JY, Chen YT.
    Circ Res; 2015 Feb 27; 116(5):876-83. PubMed ID: 25605650
    [Abstract] [Full Text] [Related]

  • 6. Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study.
    Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, La Torre F, Rigante D.
    Clin Exp Rheumatol; 2012 Feb 27; 30(5):799-804. PubMed ID: 23020938
    [Abstract] [Full Text] [Related]

  • 7. Clinical manifestations of Kawasaki disease: what are the significant parameters?
    Chaiyarak K, Durongpisitkul K, Atta T, Soongswang J, Laohaprasitiporn D, Nana A.
    Asian Pac J Allergy Immunol; 2009 Feb 27; 27(2-3):131-6. PubMed ID: 19839499
    [Abstract] [Full Text] [Related]

  • 8. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y, Zheng Q, Zou L, Wu J, Guo L, Teng L, Zheng R, Jung LKL, Lu M.
    Pediatr Rheumatol Online J; 2019 Jan 05; 17(1):1. PubMed ID: 30611297
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses.
    Li Z, Tan Z, Hao S, Jin B, Deng X, Hu G, Liu X, Zhang J, Jin H, Huang M, Kanegaye JT, Tremoulet AH, Burns JC, Wu J, Cohen HJ, Ling XB, Emergency Medicine Kawasaki Disease Research Group.
    PLoS One; 2016 Jan 05; 11(2):e0146733. PubMed ID: 26859297
    [Abstract] [Full Text] [Related]

  • 11. A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease.
    Whitin JC, Yu TT, Ling XB, Kanegaye JT, Burns JC, Cohen HJ.
    PLoS One; 2016 Jan 05; 11(6):e0157024. PubMed ID: 27271757
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis.
    Xiu-Yu S, Jia-Yu H, Qiang H, Shu-Hui D.
    J Clin Lab Anal; 2010 Jan 05; 24(6):385-8. PubMed ID: 21089168
    [Abstract] [Full Text] [Related]

  • 14. Acute-phase reactants and a supplemental diagnostic aid for Kawasaki disease.
    Huang MY, Gupta-Malhotra M, Huang JJ, Syu FK, Huang TY.
    Pediatr Cardiol; 2010 Nov 05; 31(8):1209-13. PubMed ID: 20957478
    [Abstract] [Full Text] [Related]

  • 15. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
    Wang L, Yang Y, Cui Q, Cui Y, Li Q, Che X, Wang C, Quan P, Hu X.
    J Investig Med; 2021 Jan 05; 69(1):13-19. PubMed ID: 33004469
    [Abstract] [Full Text] [Related]

  • 16. A novel score system of blood tests for differentiating Kawasaki disease from febrile children.
    Tsai CM, Chu CH, Liu X, Weng KP, Liu SF, Huang YH, Kuo HC.
    PLoS One; 2021 Jan 05; 16(1):e0244721. PubMed ID: 33481812
    [Abstract] [Full Text] [Related]

  • 17. Changes in and significance of platelet function and parameters in Kawasaki disease.
    Zheng X, Wu W, Zhang Y, Wu G.
    Sci Rep; 2019 Nov 27; 9(1):17641. PubMed ID: 31776411
    [Abstract] [Full Text] [Related]

  • 18. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
    Rong X, Jia L, Hong L, Pan L, Xue X, Zhang C, Lu J, Jin Z, Qiu H, Wu R, Chu M.
    J Cardiovasc Transl Res; 2017 Feb 27; 10(1):1-8. PubMed ID: 27981487
    [Abstract] [Full Text] [Related]

  • 19. A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.
    Ling XB, Lau K, Kanegaye JT, Pan Z, Peng S, Ji J, Liu G, Sato Y, Yu TT, Whitin JC, Schilling J, Burns JC, Cohen HJ.
    BMC Med; 2011 Dec 06; 9():130. PubMed ID: 22145762
    [Abstract] [Full Text] [Related]

  • 20. Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses.
    Hao S, Ling XB, Kanegaye JT, Bainto E, Dominguez SR, Heizer H, Jone PN, Anderson MS, Jaggi P, Baker A, Son MB, Newburger JW, Ashouri N, McElhinney DB, Burns JC, Whitin JC, Cohen HJ, Tremoulet AH, Pediatric Emergency Medicine Kawasaki Disease Research Group.
    Arch Dis Child; 2020 Aug 06; 105(8):772-777. PubMed ID: 32139365
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.